Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | APEX1 | P27695 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | PPM1B | O75688 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.47 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL390785 | 1.00 | POLB (0.56) | POLBALDH1A1SMN1; SMN2KDM4EAPEX1 | |
| SCHEMBL960068 | 1.00 | POLB (0.56) | POLBALDH1A1SMN1; SMN2KDM4EAPEX1 | |
| SCHEMBL3344598 | 1.00 | POLB (0.56) | POLBALDH1A1SMN1; SMN2KDM4EAPEX1 | |
| SCHEMBL12268155 | 1.00 | POLB (0.56) | POLBALDH1A1SMN1; SMN2KDM4EAPEX1 | |
| SCHEMBL392898 | 1.00 | POLB (0.56) | POLBALDH1A1SMN1; SMN2KDM4EAPEX1 | |
| SCHEMBL1286040 | 1.00 | POLB (0.56) | POLBALDH1A1SMN1; SMN2KDM4EAPEX1 | |
| SCHEMBL15382009 | 1.00 | POLB (0.56) | POLBALDH1A1SMN1; SMN2KDM4EAPEX1 | |
| SCHEMBL390569 | 1.00 | POLB (0.56) | POLBALDH1A1SMN1; SMN2KDM4EAPEX1 | |
| SCHEMBL12268152 | 1.00 | POLB (0.56) | POLBALDH1A1SMN1; SMN2KDM4EAPEX1 | |
| SCHEMBL6737297 | 1.00 | POLB (0.56) | POLBALDH1A1SMN1; SMN2KDM4EAPEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4725937-A1 | PROCESS FOR THE SYNTHESIS OF BICYCLIC CARBOXAMIDE COMPOUNDS | Acousia Therapeutics GmbH (DE) | 2026-04-15 | — | — | EP | claimed |
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| US-10072043-B2 | Inhibitors of protein tyrosine phosphatases | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2018-09-11 | — | — | US | claimed |
| US-20160176922-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | Indiana University Research and Technology Corpora tion (US) | 2016-06-23 | — | — | US | claimed |
| US-9217012-B2 | Inhibitors of protein tyrosine phosphatases | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2015-12-22 | — | — | US | claimed |
| US-20120088720-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATI (US) | 2012-04-12 | — | — | US | claimed |
| WO-2010118241-A2 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION (US) | 2010-10-14 | — | — | WO | claimed |
| US-6348296-B1 | COPOLYMER CONSISTING OF 2,3-DI-TERT-BUTYL-5-NORBORNENE-2,3-DICARBOXYLATE, ANOTHER NORBORNENE MONOMER, AND MALEIC ANHYDRIDE | HYUNDAI ELECTRONICS INDUSTRIES CO., LTD. (KR) | 2002-02-19 | — | — | US | claimed |
| WO-2026082324-A1 | PROCESS FOR THE SYNTHESIS OF BICYCLIC CARBOXAMIDE COMPOUNDS | ACOUSIA THERAPEUTICS GMBH (DE) | 2026-04-23 | — | — | WO | disclosed |
| EP-4725937-A1 | PROCESS FOR THE SYNTHESIS OF BICYCLIC CARBOXAMIDE COMPOUNDS | Acousia Therapeutics GmbH (DE) | 2026-04-15 | — | — | EP | disclosed |
| EP-4725937-A1 | PROCESS FOR THE SYNTHESIS OF BICYCLIC CARBOXAMIDE COMPOUNDS | Acousia Therapeutics GmbH (DE) | 2026-04-15 | — | — | EP | disclosed |
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | disclosed |
| WO-2025031481-A1 | RXFP1 RECEPTOR MODULATOR AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF | 深圳信立泰药业股份有限公司 | 2025-02-13 | — | — | WO | disclosed |
| US-20020042406-A1 | Ring opening metathesis of alkenes | CUNY GREGORY D (US) | 2002-04-11 | — | — | US | disclosed |
| US-6369181-B1 | COMONOMERS COMPRISING 5-NORBORNENE-2-CARBOXYLIC ACID ESTERS, 5-NORBORNENE-2,3-DICARBOXYLIC ACID MONOMETHYL ESTER, AND MALEIC ANHYDRIDE; ODORLESS; ULTRAVIOLET RAYS OF KRYPTON FLUORIDE OR ARGON FLUORIDE | HYUNDAI ELECTRONICS INDUSTRIES CO., LTD. (KR) | 2002-04-09 | — | — | US | disclosed |
| US-6348296-B1 | COPOLYMER CONSISTING OF 2,3-DI-TERT-BUTYL-5-NORBORNENE-2,3-DICARBOXYLATE, ANOTHER NORBORNENE MONOMER, AND MALEIC ANHYDRIDE | HYUNDAI ELECTRONICS INDUSTRIES CO., LTD. (KR) | 2002-02-19 | — | — | US | disclosed |
| US-20020015912-A1 | Photoresist monomers, polymers thereof and photoresist compositions containing the same | HYNIX SEMICONDUCTOR INC. (KR) | 2002-02-07 | — | — | US | disclosed |
| US-20010034341-A1 | Ring opening metathesis of alkenes | CUNY GREGORY D (US) | 2001-10-25 | — | — | US | disclosed |
| US-6177464-B1 | BACTERICIDES | SEPRACOR, INC. | 2001-01-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10072043-B2 | Inhibitors of protein tyrosine phosphatases | PTPRCAP, PTPRF, PTPRS | POLB 4097/4885ALDH1A1 3087/4885SMN1; SMN2 4271/4885 |
| US-20010034341-A1 | Ring opening metathesis of alkenes | LSS, BAK1, LTC4S | POLB 408/4885ALDH1A1 1453/4885SMN1; SMN2 3052/4885 |
| US-20160176922-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | PTPRCAP, PTPRF, PTPRS | POLB 4097/4885ALDH1A1 3087/4885SMN1; SMN2 4271/4885 |
| US-20120088720-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | PTPRCAP, PTPRF, PTPRS | POLB 4097/4885ALDH1A1 3087/4885SMN1; SMN2 4271/4885 |
| US-20020042406-A1 | Ring opening metathesis of alkenes | LSS, BAK1, LTC4S | POLB 408/4885ALDH1A1 1453/4885SMN1; SMN2 3052/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.